<DOC>
	<DOCNO>NCT01919333</DOCNO>
	<brief_summary>This aim study evaluate impact endometrioma laparoscopic cystectomy ovarian reserve measure serum antimullerian hormone study different effect level serum antimullerian hormone laparoscopic cystectomy non-ovarian pelvic surgery .</brief_summary>
	<brief_title>Anti-Mullerian Hormone Changes After Laparoscopic Ovarian Cystectomy Endometrioma Compared With Non-ovarian Conditions</brief_title>
	<detailed_description />
	<criteria>â€¢ Participants must age 18 45 enter study . Every participant completely understand process study write informed consent . Having regular menstrual cycle ( 2135 day ) time operation evidence endocrine disorder diabetes mellitus , thyroid dysfunction , hyperprolactinemia , congenital adrenal hyperplasia , Cushing 's syndrome , adrenal insufficiency . undergo laparoscopic ovarian cystectomy laparoscopic non ovarian pelvic surgery benign pelvic disease No previous history adnexal surgery No suspicious finding malignant ovarian disease Never take medication oral pill hormonal drug within 3 month enrollment . pathological diagnosis excise ovarian tissue confirm endometriotic cyst study group benign pelvic disease control group polycystic ovarian syndrome accord Rotterdam criterion pathological report malignant disease operation conversion openlaparotomy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>